VIVO BIO TECH | SWADESHI POLYTEX | VIVO BIO TECH/ SWADESHI POLYTEX |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 37.2 | 3.0 | 1,258.0% | View Chart |
P/BV | x | 1.2 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
VIVO BIO TECH Mar-21 |
SWADESHI POLYTEX Mar-21 |
VIVO BIO TECH/ SWADESHI POLYTEX |
5-Yr Chart Click to enlarge
|
||
High | Rs | 71 | 8 | 870.7% | |
Low | Rs | 18 | 3 | 557.1% | |
Sales per share (Unadj.) | Rs | 38.6 | 0 | - | |
Earnings per share (Unadj.) | Rs | 4.2 | -0.4 | -1,008.7% | |
Cash flow per share (Unadj.) | Rs | 8.4 | -0.4 | -2,018.7% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 30.6 | -8.7 | -351.5% | |
Shares outstanding (eoy) | m | 13.42 | 39.00 | 34.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.2 | 0 | - | |
Avg P/E ratio | x | 10.5 | -13.5 | -77.7% | |
P/CF ratio (eoy) | x | 5.3 | -13.6 | -38.8% | |
Price / Book Value ratio | x | 1.5 | -0.7 | -222.9% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 597 | 221 | 269.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 86 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 518 | 0 | - | |
Other income | Rs m | 1 | 2 | 57.6% | |
Total revenues | Rs m | 519 | 2 | 29,309.0% | |
Gross profit | Rs m | 178 | -22 | -819.9% | |
Depreciation | Rs m | 56 | 0 | 39,935.7% | |
Interest | Rs m | 37 | 0 | - | |
Profit before tax | Rs m | 86 | -20 | -429.9% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 29 | -4 | -795.9% | |
Profit after tax | Rs m | 57 | -16 | -347.1% | |
Gross profit margin | % | 34.3 | 0 | - | |
Effective tax rate | % | 34.1 | 18.4 | 185.3% | |
Net profit margin | % | 11.0 | 0 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 271 | 70 | 386.6% | |
Current liabilities | Rs m | 218 | 466 | 46.9% | |
Net working cap to sales | % | 10.1 | 0 | - | |
Current ratio | x | 1.2 | 0.2 | 824.9% | |
Inventory Days | Days | 0 | 0 | - | |
Debtors Days | Days | 51,413,598 | 0 | - | |
Net fixed assets | Rs m | 524 | 31 | 1,716.6% | |
Share capital | Rs m | 134 | 39 | 344.1% | |
"Free" reserves | Rs m | 277 | -379 | -73.1% | |
Net worth | Rs m | 411 | -340 | -121.0% | |
Long term debt | Rs m | 147 | 0 | - | |
Total assets | Rs m | 795 | 101 | 790.6% | |
Interest coverage | x | 3.3 | 0 | - | |
Debt to equity ratio | x | 0.4 | 0 | - | |
Sales to assets ratio | x | 0.7 | 0 | - | |
Return on assets | % | 11.8 | -16.3 | -72.3% | |
Return on equity | % | 13.8 | 4.8 | 287.0% | |
Return on capital | % | 22.1 | 5.9 | 373.6% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 19 | 0 | - | |
Fx outflow | Rs m | 42 | 0 | - | |
Net fx | Rs m | -23 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 142 | -22 | -650.3% | |
From Investments | Rs m | -228 | 1 | -17,031.3% | |
From Financial Activity | Rs m | 88 | NA | - | |
Net Cashflow | Rs m | 1 | -20 | -6.7% |
Indian Promoters | % | 42.2 | 63.2 | 66.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.1 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 57.8 | 36.8 | 157.2% | |
Shareholders | 12,632 | 10,474 | 120.6% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare VIVO BIO TECH With: VA TECH WABAG DELTA CORP SANGHVI MOVERS SIS SUN PHARMA ADV. RES.
Indian share markets settled near four-month highs as fag-end buying in Reliance Industries' and other index heavyweight stocks pushed benchmark indices off their day's low.